• ST3GAL1, Sialylation, and F. nucleatum Adhesion

  2026-08-27

  This study identifies ST3GAL1-dependent sialylation as a host-cell determinant of Fusobacterium nucleatum adhesion to colorectal cancer cells. It further connects persistent bacterial colonization with an H3K27ac–ANGPTL4 pathway, offering a mechanistic framework for understanding how tumor glycosylation may support intratumoral microbiota retention.

• Toremifene Assays: From ER Biology to Bone Metastasis

  2026-08-27

  Toremifene offers a research framework for connecting estrogen receptor modulation with prostate cancer cell phenotypes. This article translates the TSPAN18–STIM1 findings into practical assay decisions while separating established evidence from testable hypotheses.

• TAK1–YAP Signaling in Gastric Cancer Stem Cells

  2026-08-26

  The reference study identifies TGFβ-activated kinase 1 (TAK1) as an IL-6-responsive regulator of YAP stability in gastric cancer stem cells. Its findings connect TAK1–YAP signaling with SOX2/SOX9 expression, cancer stem cell self-renewal, and tumorigenesis, providing a mechanistic framework for studying gastric cancer progression.

• Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance

  2026-08-26

  The reference study developed a tumor-microenvironment pH-responsive nanoparticle system for systemic delivery of PTEN mRNA to trastuzumab-resistant breast cancer. Its central finding is that restoring PTEN expression can inhibit persistently active PI3K/Akt signaling, providing a mechanistically targeted strategy for re-sensitizing resistant tumors to trastuzumab.

• Serine/Glycine Restriction and PD-L1 Lactylation

  2026-08-25

  The reference study shows that a serine/glycine-free diet can restrain colorectal cancer growth while increasing cytotoxic T-cell activity, but may also promote immune escape through PD-L1 lactylation. Its combination of mechanistic tumor studies and an early clinical feasibility study provides a useful framework for evaluating nutrient-restricted diets alongside immune checkpoint therapy.

• Direct Mouse Genotyping Kit Plus for Macrophage Studies

  2026-08-25

  Connect rapid, purification-free mouse genotyping with lineage-tracing, transgene, and knockout workflows in immuno-oncology research. This practical guide shows how to use direct lysates, high-fidelity PCR, and dye-enabled electrophoresis while avoiding common inhibitors and genotype miscalls.

• Estradiol: From Receptor Bias to Organ-Level Assays

  2026-08-24

  Estradiol and 17 beta-estradiol are powerful tools for connecting estrogen receptor signaling with tissue-level biology. This article presents an assay-interpretation framework that links receptor context, autophagy, and organ protection without confusing correlation with mechanism.

• Meropenem Trihydrate: From Mechanism to Translation

  2026-08-24

  Meropenem trihydrate can serve as more than a broad-spectrum antibacterial control. By pairing its penicillin-binding protein mechanism with LC-MS/MS metabolomics, researchers can connect resistance phenotypes to measurable metabolic states and build more translational infection models.

• Standardized Whole-Blood Immunometabolism Assay

  2026-08-23

  Zhao and colleagues present a standardized whole-blood stimulation protocol for testing how metabolic interventions shape human immune responses. By combining defined immune stimuli, pathway-directed inhibitors, and cytokine quantification, the workflow supports reproducible immunometabolism research while preserving the cellular complexity of whole blood.

• EGTA for Calcium Signaling Assay Design

  2026-08-22

  EGTA, or egtazic acid, offers a practical way to test whether extracellular calcium drives neuronal injury, synaptic excitation, inflammation, or apoptosis. This workflow-focused guide connects selective calcium chelation with electrophysiology, cell viability assays, and troubleshooting strategies for reproducible experiments.

• Pifithrin-α: p53 Inhibitor Evidence & Workflow

  2026-08-22

  Pifithrin-α is a p53 inhibitor used to test p53-dependent apoptosis, growth arrest, and ferroptosis mechanisms. Evidence from irradiated cellular models and a deltamethrin neurotoxicity study supports mechanistic use, but does not establish clinical cancer therapy side effect mitigation.

• Fraxinellone Activates PINK1/Parkin Mitophagy in IBD

  2026-08-21

  The reference study identifies fraxinellone as a potential modulator of mitochondrial quality control in inflammatory bowel disease. Using DSS and LPS injury models, molecular docking, CETSA, and PINK1 knockdown, the authors link fraxinellone protection to PINK1/Parkin-dependent mitophagy rather than to nonspecific anti-inflammatory activity alone.

• BCECF for Extracellular pH Assays

  2026-08-20

  BCECF provides a ratiometric way to connect extracellular acidity with ion transport, macrophage function, and disease-model biology. This practical guide explains how to calibrate the probe, integrate it with efferocytosis workflows, and avoid confusing extracellular pH changes with intracellular readouts.

• DCPS and m7G Signaling in Diabetic Foot Ulcers

  2026-08-20

  A 2025 study identified the decapping scavenger enzyme DCPS as an m7G-related biomarker associated with diabetic foot ulcer biology. Integrating transcriptomic analysis with keratinocyte perturbation experiments, the authors linked reduced DCPS to impaired cell-cycle progression, proliferation, migration, and increased apoptosis, providing a testable framework for epithelial wound-healing research.

• TUDCA Workflows for ER Stress and NAFLD Research

  2026-08-19

  Tauroursodeoxycholic Acid gives researchers a practical chemical-chaperone approach for separating ER stress, mitochondrial injury, apoptosis, and autophagy defects. This workflow connects TUDCA treatment with the Galectin-1–FIP200 mechanism reported in hepatic steatosis, enabling more discriminating metabolic disease assays.

8040 records 1/536 page Next 12345 下5页 Last page